Results 61 to 70 of about 21,523 (174)

Anticoagulantes orales directos en el tratamiento de la trombosis venosa asociada a cáncer. [PDF]

, 2020
La trombosis asociada a cáncer (TAC) es la segunda causa de muerte en pacientes con cáncer. Hasta ahora la terapia estándar es con HBPM (heparina de bajo peso molecular) al menos durante el período inicial.

core  

Sleep characteristics and self‐reported sleep quality in the oldest‐old: Results from a prospective longitudinal cohort study

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Little is known about the correlation between subjective perception and objective measures of sleep quality in particular in the oldest‐old. The aim of this study was to perform longitudinal home sleep monitoring in this age group, and to correlate results with self‐reported sleep quality.
Hugo Saner, Kevin Möri, Narayan Schütz, Philipp Buluschek, Tobias Nef   +4 more
wiley   +1 more source

Estrategias de reperfusión coronaria en el infarto agudo de miocardio con elevación del segmento ST: de la teoría a la práctica en el Hospital Clínico Universitario de Valladolid [PDF]

, 2017
La cardiopatía isquémica es la primera causa de mortalidad en España y el síndrome coronario agudo, su forma de presentación más frecuente y una de las más letales.
Moreno Molinero, Ana
core  

Vasculitis leucocitoclástica secundaria a nuevos anticoagulantes orales [PDF]

, 2020
Sr. Director: Los nuevos anticoagulantes orales (NACO) son cada vez más empleados en la prevención de ictus en pacientes con fibrilación auricular, y en la prevención y tratamiento de las trombosis venosas profundas y embolismos pulmonares1.
Ara Martín, M., García García, M., Martínez Pallás, I., Torrubia Pérez, C.B.   +3 more
core   +1 more source

Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Procedural and clinical outcomes in patients with obesity undergoing catheter ablation for atrial fibrillation (AF) have been mixed. Clinical data in the context of pulsed field ablation (PFA) are currently limited in this patient cohort.
Francis J. Ha, Duron Prinsloo, Edwin Xu, Hui Chen Han, Nitesh Nerlekar, Adam J. Brown, Emily Kotschet   +6 more
wiley   +1 more source

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects

Clinical Pharmacology: Advances and Applications, 2013
Yimin Cui,1 Yan Song,2 Jessie Wang,2 Zhigang Yu,2 Alan Schuster,2 Yu Chen Barrett,2 Charles Frost2 1Peking University First Hospital, Beijing, People's Republic of China; 2Bristol-Myers Squibb, Princeton, NJ, USA Background: The pharmacokinetics (PK),
Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C   +6 more
doaj  

Electronic monitoring of adherence to once‐daily and twice‐daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP‐AF trial

Journal of Arrhythmia, 2021
Background Nonadherence diminishes the efficacy of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (NVAF). This report presents the baseline survey results regarding medication adherence among NVAF patients who were ...
Tsuyoshi Shiga, Toshimi Kimura, Noritoshi Fukushima, Yuji Yoshiyama, Kazunori Iwade, Fumiaki Mori, Yoichi Ajiro, Shoji Haruta, Yuichiro Yamada, Emi Sawada, Nobuhisa Hagiwara, the SMAAP‐AF investigators   +11 more
doaj   +1 more source

Resultados clínicos de terapia antitrombótica con anticoagulantes orales de acción directa tras implante de stent [PDF]

, 2023
La coexistencia de intervencionismo coronario percutáneo (ICP) con implante de stent y fibrilación auricular (FA) es frecuente en la práctica clínica habitual.
Fuertes Ferre, Georgina, Linares Vicente, José Antonio, Martínez Fleta, Mario   +2 more
core  

Early Mobilization After Pacemaker Implantation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The increasing use of cardiac implantable electronic devices (CIED) is leading to a rise in procedure‐related complications. Objective This trial aimed to assess the safety and feasibility of early mobilization and the possibility of same‐day discharge following permanent pacemaker implantation.
Jiří Šmíd, Vlastimil Vančura, Martin Brada, Richard Rokyta   +3 more
wiley   +1 more source

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol

Journal of Comparative Effectiveness Research, 2023
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation (NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study on patients with NVAF who started their treatment with apixaban or ...
Josep Comin Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchia, Isabel del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sanchez   +6 more
doaj   +1 more source